Michael Cannon
Michael Cannon is the director of health policy studies at the Cato Institute, a libertarian think tank based in Washington, D.C. He is known for his expertise in health care policy, particularly regarding the implications of government intervention in the pharmaceutical market. Cannon has been vocal about the potential negative consequences of price control measures, arguing that similar policies in other sectors have historically led to shortages and inefficiencies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 3 | 4.33 | 0.14% | +10% | 331,002,651 | 510,425 | $21,000,000 | 32,383$ |
| Totals | 3 | 331,002,651 | 510,425 | $21,000,000 | 32,383$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Michael Cannon, the director of health policy studies at the libertarian Cato Institute, criticized the proposal.
3
United States:
Michael Cannon stated that extending the enhanced subsidies would likely depress Republican turnout in the midterms.
5
United States:
Michael Cannon, director of health policy studies at the Cato Institute, discusses the impact of Obamacare on healthcare prices.
5
Switzerland:
Michael Cannon from the Cato Institute stated that Obamacare has led to skyrocketing premiums.
4
United States:
Michael Cannon discussed the anti-establishment backlash affecting public health and the medical community.
5
United States:
Michael Cannon, Director of Health Policy Studies at the Cato Institute, stated that it is reasonable for taxpayers to insist that everyone in the Medicaid program who can contribute do so.
6
United States:
Michael Cannon, director of health policy studies at the Washington-based libertarian-leaning Cato Institute think tank, commented on the implications of price controls.
5